Search Results 761-770 of 5826 for albumin
Albumin >= 2.5 g/dL (within 2 weeks of patient registration [for blood results] and 30 days of registration for LVEF assessment). Total bilirubin =< 1.5 x ...
About this study. To develop a repository of blood, urine and tissue samples from patients with ILD to support future studies into the development of such ...
About this study. This Registry will enroll cirrhotic participants with or without decompensated liver disease who have achieved a sustained virologic ...
... . VID-20249239. Home; Why choose mayo lung transplant. Have 2X the impact! Give Today. The deadline to have twice the impact to advance healthcare ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Microcalcifications in benign breast biopsies: association with lesion type and risk. Breast Cancer Res Treat. 2024 Dec; 208(3):543-551. Epub 2024 Sep 04. View ...
Regenerative therapies offer a more natural and less invasive approach to facial plastic surgery and aesthetic medicine. The use of exosomes (extracellular ...
The deadline to have twice the impact to advance healthcare research is May 15. Give Today.
Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...
About this study. The purpose of this study is to determine the accuracy (sensitivity, specificity, negative predictive value, positive predictive value) of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.